8 min read

Analyst Hints & Ratings — November 21, 2026 — Midday Update — Last 48 Hours (Pacific Time)

Analyst sentiment turned mildly bearish over the past 48 hours, with price target cuts outnumbering raises. Bill.com faced a mass downgrade following its TPG acquisition announcement, while Intuit suffered broad PT cuts on earnings disappointments. Bright spots included Walmart (near-universal raise

Executive Summary

The past 48 hours saw a heavily active analyst tape dominated by price target cuts, particularly concentrated in Intuit, Elastic, and retail names, reflecting earnings disappointments and AI-related headwinds. Bill.com was the single most-downgraded stock of the period, with at least seven firms cutting ratings following its TPG acquisition announcement. Bright spots emerged in Walmart (near-universal PT raises), healthcare upgrades (UnitedHealth, Humana), and cybersecurity (Palo Alto Networks), while the Bill.com acquisition and Intuit's Credit Karma concerns drove the most bearish consensus shifts.


Analyst Action Breakdown

Action Type Count Percentage
Upgrades 16 ~9%
Downgrades 22 ~13%
PT Raises 47 ~27%
PT Cuts 51 ~29%
Reiterations (no PT change) 27 ~15%
Initiations 12 ~7%

Net Sentiment: 🔴 Mildly Bearish / Mixed

Downgrades and PT cuts outnumber upgrades and PT raises in this window. While several high-profile names received bullish reiterations and raises (Walmart, Palo Alto, Airbnb), the volume of cuts — especially on Intuit, Elastic, Bill.com, and retail — tilts the tape bearish on balance.


Top Analyst Calls

🔴 JPMorgan → Bill.com (BILL) — Downgraded to Neutral from Overweight

  • Raised PT to an undisclosed level; downgrade follows the TPG acquisition deal announcement, joining a wave of six other firms cutting the stock.

🔴 Multiple Firms → Bill.com (BILL) — Mass Downgrade Event

  • TD Cowen, UBS, Jefferies, BTIG, Needham, and Oppenheimer all downgraded BILL to Hold/Neutral/Perform following the TPG acquisition; PT consensus converges near $63.

🟢 TD Cowen → Walmart (WMT) — Raised PT to $147 from $125, maintains Buy

  • Firm cites accelerating e-commerce growth as the key driver behind one of the largest PT raises on WMT this cycle.

🟢 DA Davidson → Walmart (WMT) — Raised PT to $145 from $132, maintains Buy

  • Margin growth cited as the primary catalyst; part of a broad-based analyst rally around Walmart's earnings.

🔴 Stifel → Marvell Technology (MRVL) — PT Cut to $280 from $370, maintains Buy

  • A $90 reduction — one of the largest absolute PT cuts in this window — driven by deal-related concerns.

🟢 TD Cowen → UnitedHealth (UNH) — Upgraded to Buy from Hold, PT raised to $455 from $402

  • Firm sees a compelling earnings recovery outlook; one of the most significant healthcare upgrades in the period.

🟢 TD Cowen → Humana (HUM) — Upgraded to Buy from Hold, PT raised to $485 from $430

  • Paired with the UNH upgrade, signaling a broad managed care sentiment shift at TD Cowen.

🔴 Multiple Firms → Intuit (INTU) — PT Cuts Across the Board

  • BMO ($375 from $412), RBC ($330 from $385), Piper Sandler ($270 from $290), Morgan Stanley ($310 from $315), BofA ($310 from $350), UBS ($315 from $360), Wells Fargo ($320 from $330), Evercore ISI ($335 from $400), and Truist (Hold, $300) all cut — Credit Karma AI risk and guidance reduction are the dominant themes.

🟢 HSBC → Tesla (TSLA) — Upgraded to Hold from Reduce, PT raised to $359 from $157

  • A dramatic $202 PT increase citing acquisition potential; one of the most eye-catching single moves in the period.

🟢 Oppenheimer → Amazon (AMZN) — PT raised to $310 from $285, maintains Outperform

  • Firm attributes the raise to increased value attributed to Amazon's Anthropic stake.

🔴 Guggenheim → X-Energy (XE) — PT Cut to $42 from $57, maintains Buy

  • A $15 reduction on valuation grounds despite the firm keeping its bullish rating.

🟢 Guggenheim → Oklo (OKLO) — Upgraded to Buy from Neutral, PT set at $38

  • Execution progress in nuclear energy cited; notable given the broader energy/nuclear theme in markets.

🔴 Cantor Fitzgerald → Powell Industries (POWL) — PT Cut to $178 from $235, maintains Overweight

  • A $57 reduction on timing concerns — significant magnitude cut on an industrial name.

🟢 TD Cowen → Klaviyo (KVYO) — PT Raised to $30 from $26, maintains Buy

  • AI growth potential flagged as the core driver; part of a broader AI-beneficiary theme.

🔴 Jefferies → Fortis (FTS) — Downgraded to Underperform from Hold

  • Arizona regulatory risk cited; a rare Underperform initiation from Jefferies on a utility name.

Firm Activity Summary

TD Cowen — 13 calls (8 bullish, 5 bearish)

  • Upgrades: UNH (Buy), HUM (Buy), EXPD (Hold from Sell)
  • Raises: WMT ($147), KVYO ($30), VVV ($43), WSM ($265 cut but Buy maintained)
  • Downgrades: BILL (Hold), WSM (PT cut)
  • Reiterations: DKNG (Buy), XPO (Buy), PYPL (Hold)

BMO Capital — 7 calls (4 bullish, 3 bearish)

  • Raises: PANW ($425), AS (reiterate Outperform)
  • Cuts: BBWI ($20), INTU ($375), NGVT ($72), BILL ($63.25)
  • Upgrade: EFOR (Outperform)

BofA Securities — 9 calls (3 bullish, 6 bearish)

  • Raises: BBY ($83), WMT ($141), WMG ($35)
  • Cuts: ROAD ($112), NTES ($163), SNOW ($400), INTU ($310), GAP ($23), BBWI ($25), HIMS ($21)

Stifel — 6 calls (4 bullish, 2 bearish)

  • Buys reiterated: CLDX, RGNX, TTMI
  • Raise: TMDX ($80)
  • Cuts: MRVL ($280), WSM ($260)

Wells Fargo — 7 calls (3 bullish, 4 bearish)

  • Raises: VVV ($42), CRWV (reiterate $115)
  • Initiation: SUPN (Overweight)
  • Reiterate: C (Overweight)
  • Cuts: KEYS ($350), ROST ($215), INTU ($320)

Mizuho — 6 calls (5 bullish, 1 neutral)

  • Outperform reiterations: MMED ($28), WVE ($23), WMT ($135)
  • Raises: BIIB ($271), INCY ($148), VVV ($42)

Jefferies — 7 calls (4 bullish, 2 bearish, 1 neutral)

  • Buys: KRYS ($474), BMEA ($5), UAL ($142)
  • Raise: GLOB ($40 from $35, Hold)
  • Hold: FLO ($5)
  • Downgrade: FTS (Underperform), BILL (Hold)
  • Cut: FUTU ($143)

DA Davidson — 8 calls (4 bullish, 3 bearish, 1 neutral)

  • Upgrades: BANR (Buy), EBMT (Buy)
  • Raises: WMT ($145), WMS (reiterate $180)
  • Downgrades: NBHC (Neutral), COFS (Neutral), BMRC (Neutral)
  • Neutral reiteration: ESTC ($85)

Piper Sandler — 5 calls (3 bullish, 2 bearish)

  • Raises: WMT ($138), WSM ($287)
  • Reiterations: SLDB (Overweight), HP (Overweight)
  • Cut: INTU ($270)

Truist Securities — 6 calls (3 bullish, 3 bearish)

  • Upgrades: EVH (Buy)
  • Raises: GLOB ($44), MTZ (reiterate $332)
  • Cuts: UTI ($26), ROST ($280), INTU (Hold, $300)

RBC Capital — 5 calls (3 bullish, 2 bearish)

  • Outperform: EW ($115), CNC ($73), VVV ($48)
  • Cuts: INTU ($330), ESTC ($105)

Bernstein SocGen — 6 calls (3 bullish, 1 bearish, 2 neutral)

  • Raises: ABNB ($234), WMG ($40)
  • Outperform reiterations: WMT ($142), NFLX ($80)
  • Market Perform: DE ($580), RVMD

Guggenheim — 4 calls (3 bullish, 1 bearish)

  • Raises: WWD ($410), WMG ($38)
  • Upgrade: OKLO (Buy, $38)
  • Cut: XE ($42)

Cantor Fitzgerald — 4 calls (2 bullish, 2 bearish)

  • Overweight reiterations: WDAY ($205), NKE ($33 cut)
  • Cuts: POWL ($178), ESTC ($75)

Baird — 3 calls (0 bullish, 3 bearish)

  • Downgrades: GWW (Neutral), FAST (Neutral), PODD (Neutral)

StoneX — 4 calls (3 bullish, 1 bearish)

  • Buys: JOYY ($94), PDD ($114), GRRR ($15 cut)
  • Cut: BABA ($160)

UBS — 6 calls (2 bullish, 4 bearish)

  • Buys: NTRA ($490), JLL ($445)
  • Downgrades: BILL (Neutral), DB1 (Sell)
  • Cuts: INTU ($315), GAP ($36)

Keefe Bruyette — 3 calls (2 bullish, 1 bearish)

  • Raises: RYAN ($55), PGR ($250)
  • Cut: BLSH ($30)

Morgan Stanley — 5 calls (2 bullish, 3 bearish)

  • Raises: WMT ($135), AS ($35)
  • Cuts: BBWI ($21), INTU ($310), KEYS ($400)

BTIG — 5 calls (3 bullish, 2 bearish)

  • Raises: PANW ($442), WMT ($140), CRS (reiterate $470)
  • Cuts: GAP ($26)
  • Downgrade: BILL (Neutral), ROST (Neutral)

Oppenheimer — 4 calls (2 bullish, 1 bearish, 1 neutral)

  • Raises: AMZN ($310), TLN ($450)
  • Reiterate: CRM ($275)
  • Downgrade: BILL (Perform)

JPMorgan — 5 calls (2 bullish, 3 bearish)

  • Initiations: MSGR (Overweight), BOKF (Neutral)
  • Downgrades: BILL (Neutral), VVV (Underweight), EMN (Underweight)

Retail & Consumer — Mixed with Downward Bias: Walmart was the standout winner, receiving PT raises from at least nine firms (TD Cowen to $147, DA Davidson to $145, KeyBanc to $145, BofA to $141, Raymond James to $140, BTIG to $140, Piper Sandler to $138, Mizuho at $135, Morgan Stanley to $135, Bernstein at $142) following strong earnings and e-commerce momentum. In contrast, Williams-Sonoma saw PT cuts from TD Cowen ($265) and Stifel ($260) on Pottery Barn concerns, while Bath & Body Works was cut by both BMO ($20) and BofA ($25) on tariff and cost pressures. Gap received cuts from BofA ($23) and BTIG ($26). The divergence between Walmart's dominance and specialty retail weakness is a clear theme.

Technology & Software — Broadly Bearish: Intuit was the most-cut stock of the period, with nine firms reducing PTs citing Credit Karma AI disruption risk and guidance reduction — a rare degree of consensus bearishness. Elastic also drew multiple cuts (Monness downgrade to Neutral, Cantor Fitzgerald to $75, Wedbush to $100, RBC to $105, DA Davidson neutral at $85) on Q3 guidance concerns. Bill.com's TPG acquisition triggered the most concentrated downgrade event of the period, with seven firms moving to Hold/Neutral. Palo Alto Networks was a bright spot, with both BMO ($425) and BTIG ($442) raising PTs on strong results.

Healthcare — Selective Upgrades: TD Cowen's simultaneous upgrades of UnitedHealth (Buy, $455) and Humana (Buy, $485) signal a meaningful managed care sentiment shift. Valvoline attracted upgrades from multiple angles — TD Cowen raised to $43, Mizuho to $42, Wells Fargo to $42, and RBC to $48 — though JPMorgan bucked the trend with a downgrade to Underweight at $35, creating notable divergence. Biotech/pharma saw mostly reiterations with selective raises (Incyte to $148, Regeneron to $1,050, Airbnb to $234).


Market Implications

The analyst tape this week sends a clear message: earnings quality and AI resilience are the new dividing lines. Walmart's near-universal PT raise cycle reflects the market's appetite for companies demonstrating real e-commerce and margin execution. Conversely, Intuit's Credit Karma problem — flagged by nine separate firms — suggests analysts are increasingly pricing in AI disruption risk for fintech platforms with legacy revenue streams. The breadth of the Intuit cuts, spanning from $270 (Piper Sandler) to $375 (BMO), indicates genuine uncertainty about the company's near-term trajectory.

The Bill.com acquisition saga is the clearest example of a catalyst-driven consensus reset. Seven firms moving simultaneously to neutral/hold signals that the deal has effectively capped near-term upside in analyst models — a pattern investors should watch as M&A activity picks up. Meanwhile, the Baird triple-downgrade of Grainger, Fastenal, and Insulet on valuation concerns suggests some analysts believe the industrial and medtech rally has run ahead of fundamentals.

The HSBC Tesla upgrade — from Reduce to Hold with a $202 PT increase to $359 — is the most dramatic single-stock move and warrants attention, though the "acquisition potential" rationale is speculative by nature. More structurally interesting is TD Cowen's managed care double-upgrade (UNH + HUM), which could signal a bottoming thesis in a sector that has faced significant pressure. Investors should also note the nuclear energy thread: Guggenheim upgraded Oklo while cutting X-Energy, suggesting firm-level differentiation within the space rather than a sector-wide call.


Key Takeaways

  • 🔴 Bill.com (BILL) — Seven firms downgraded simultaneously on TPG acquisition; near-term upside appears capped near $63 per analyst consensus.
  • 🟢 Walmart (WMT) — Nine+ firms raised PTs following earnings; e-commerce and margin execution driving one of the broadest bullish consensus moves of the period.
  • 🔴 Intuit (INTU) — Nine firms cut PTs, citing Credit Karma AI risk and guidance reduction; widest PT range ($270–$375) signals high uncertainty.
  • 🟢 UnitedHealth (UNH) & Humana (HUM) — TD Cowen upgraded both to Buy simultaneously, signaling a managed care sentiment inflection.
  • 🔴 Marvell Technology (MRVL) — Stifel cut PT by $90 (to $280 from $370) — one of the largest absolute reductions in the period — on deal concerns.
  • 🟢 Tesla (TSLA) — HSBC raised PT by $202 to $359 on acquisition potential; most dramatic single PT move in the window.
  • 🔴 Elastic (ESTC) — Five analysts cut PTs and Monness downgraded to Neutral; Q3 guidance miss driving broad reassessment.
  • 🟢 Palo Alto Networks (PANW) — Both BMO and BTIG raised PTs on strong results; cybersecurity remains a consensus Buy.
  • 🔴 Baird triple downgrade — Grainger (GWW), Fastenal (FAST), and Insulet (PODD) all cut to Neutral on valuation; industrial/medtech rally may be stretched.
  • 🟢 Valvoline (VVV) — Four firms raised PTs (TD Cowen, Mizuho, Wells Fargo, RBC); JPMorgan's Underweight downgrade is a notable contrarian outlier.
  • 🔴 Alibaba (BABA) — Both StoneX and Citi cut PTs to $160; U.S. export restrictions and cloud revenue outlook driving bearish consensus.
  • 🟢 Oklo (OKLO) — Guggenheim upgraded to Buy ($38); nuclear energy execution progress gaining analyst recognition.
  • 🔴 Fortis (FTS) — Jefferies downgraded to Underperform on Arizona regulatory risk; rare bearish call on a utility.
  • 🟢 Amazon (AMZN) — Oppenheimer raised PT to $310 from $285, citing Anthropic stake value as an underappreciated asset.
  • 🔴 Keysight Technologies (KEYS) — Both Morgan Stanley ($400) and Wells Fargo ($350) cut PTs on AI valuation pullback and broader valuation concerns.
  • 🟢 Anthropic (ANT) — William Blair initiated with Outperform; one of the first formal analyst coverage initiations on the AI lab.
  • 🔴 Gap (GAP) — BofA, BTIG, and UBS all cut PTs; Old Navy customer pressure and revised guidance driving broad bearishness.
  • 🟢 Airbnb (ABNB) — Bernstein raised PT to $234 from $217 on growth outlook; travel demand narrative intact.
  • 🔴 Snowflake (SNOW) — BofA cut PT to $400 from $470 on growth expectations; cloud data growth deceleration concerns persist.
  • 🟢 Incyte (INCY) — Mizuho raised PT to $148 from $137 on execution; a quiet but meaningful biotech PT raise.

Independent, data-driven signals.
No hype. No promotions. Just experimental market research from EverHint.

👉 This is not financial advice. Market conditions change rapidly.
Do your own due diligence.
See https://www.everhint.com/disclaimer/ and https://www.everhint.com/faqs/